Events - Event View
This is the "Event Detail" view, showing all available information for this event.
If the event has passed, click the "Event Report" icon to read a report and view photos that were uploaded.
OPPA Spring Conference 2025
Contact(s)
Jade Deitrick
Event Coordination
Registration Info
Registration is required
Payment In Full In Advance Only
CME Accreditation Statement: In support of improving patient care, this activity has been planned and implemented by the American Psychiatric Association (APA) and the Oregon Psychiatric Physicians Association (OPPA). APA is jointly accredited by the American Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
CME Designation Statement: The APA designates this live activity for a maximum of 8 AMA PRA Category 1 Credit ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
About this event
Saturday, March 15, 2025 | Virtual Conference Agenda
| TIME |
TOPIC |
SPEAKER |
| SATURDAY, March 15, 2025 |
8:00 - 8:15 AM
|
Welcome/Introduction |
Gen Tanaka, MD
OPPA President
|
| 8:15 - 9:15 AM |
Deflection: Core Concepts and Oregon’s Implementation for HB4002 |
Eleasa Sokolski, MD
Dan Hoover, MD |
| 9:15 - 10:15 AM |
Cannabis and Psychosis |
Beatriz Carlini, MD |
| 10:15 - 10:30 AM |
Break
|
|
| 10:30 - 11:30 AM |
Substance Use Disorders in Oregon’s Indigenous Community
|
Danica Brown, PhD |
| 11:30 - 12:30 PM |
Where does it hurt? A patient-centered approach to pain management in the setting of an opioid use disorder.
|
Kyle Sears, MD |
| 12:30 - 1:00 PM |
Lunch Break and Membership Meeting |
|
| 1:00 - 2:00 PM |
Current Research and the Neuroscience Related to Addiction |
Bill Griesar, PhD |
| 2:00 - 3:00 PM |
The Rising Tide of Stimulants
|
Trey Meeks, MD |
| 3:00 - 3:15 PM |
Break |
|
3:15 - 4:15 PM
|
Reconsidering the Usefulness of Adding Naloxone to Buprenorphine |
Chris Blazes, MD |
| 4:15 - 5:15 PM |
Beware of Serotonin Syndrome with Buprenorphine in this Era of Polypharmacy!! |
Mary McCarthy, MD |
5:15 - 5:30 PM
|
Final Remarks |
Gen Tanaka, MD |
Invalid Quantity